← Study Library
Meta-analysis · 2016 · n=1,055
Promisingcounts toward this tierEffect of Leukocyte Concentration on the Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis
Riboh JC, Saltzman BM, Yanke AB, et al. · The American Journal of Sports Medicine
Promisingcounts toward this tier
LP-PRP improved WOMAC vs HA (MD -21.14) and vs placebo (MD -17.84); LR-PRP showed no significant difference vs either. No head-to-head LP vs LR trials — the leukocyte claim rests on indirect comparison.
- Population
- 9 studies (6 level 1 RCTs, 3 level 2 prospective) in knee OA
- Intervention
- Leukocyte-poor PRP vs leukocyte-rich PRP (network comparison)
- Comparator
- Hyaluronic acid and placebo
- Limitations
- Indirect network comparisons only; heterogeneous PRP preparations; PRP had higher adverse-reaction odds than HA (OR 5.63, mostly transient).
Cited by
1 entry references this study
- Platelet-rich plasma (PRP)PROM.
Injections → Biologics